21178111000001101: Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\UK product\Virtual medicinal product\Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\UK product\Virtual therapeutic moiety\Ivacaftor\Product containing only ivacaftor in oral dose form (medicinal product form)\Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\UK product\Virtual therapeutic moiety\Ivacaftor\Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\UK product\Trade family\Kalydeco\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing cystic fibrosis transmembrane conductance regulator potentiator\Product containing ivacaftor\Ivacaftor\Product containing only ivacaftor in oral dose form (medicinal product form)\Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing cystic fibrosis transmembrane conductance regulator potentiator\Product containing ivacaftor\Ivacaftor\Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing cystic fibrosis transmembrane conductance regulator potentiator\Product containing ivacaftor\Product containing ivacaftor in oral dose form (medicinal product form)\Product containing only ivacaftor in oral dose form (medicinal product form)\Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing quinoline\Product containing ivacaftor\Ivacaftor\Product containing only ivacaftor in oral dose form (medicinal product form)\Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing quinoline\Product containing ivacaftor\Ivacaftor\Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing quinoline\Product containing ivacaftor\Product containing ivacaftor in oral dose form (medicinal product form)\Product containing only ivacaftor in oral dose form (medicinal product form)\Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing ivacaftor in oral dose form (medicinal product form)\Product containing only ivacaftor in oral dose form (medicinal product form)\Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet\Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Sep 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

144841000001116 Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

144851000001118 Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Is a	Ivacaftor 150mg tablets	false	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has specific active ingredient	Ivacaftor	false	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Is a	Kalydeco	true	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has specific active ingredient	Ivacaftor	true	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has active ingredient	Ivacaftor	false	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Is a	Product containing precisely ivacaftor 150 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 56 tablet 4 x 14 tablets	Has AMP	True	Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Inferred relationship	Existential restriction modifier
Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets	Has AMP	True	Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
144841000001116	Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
144851000001118	Kalydeco 150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module